Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 5

Therapeutics and Clinical Risk Management


Archive: Volume 4, 2008


Brain abscess as a manifestation of spinal dermal sinus

Parisa Emami-Naeini, Ali Mahdavi, Hamed Ahmadi, Nima Baradaran, Farideh Nejat

Therapeutics and Clinical Risk Management 2008, 4:1143-1147

Published Date: 10 October 2008

Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

Debra L Breneman, Timothy J Storer, John C Breneman, Diya F Mutasim

Therapeutics and Clinical Risk Management 2008, 4:1135-1141

Published Date: 10 October 2008

A pilot feasibility study of daily rTMS to modify corticospinal excitability during lower limb immobilization

Raffaella Ricci, Dave Ramsey, Kevin Johnson, Jeffrey J Borckardt, Matthew Vallejo, et al

Therapeutics and Clinical Risk Management 2008, 4:1127-1134

Published Date: 10 October 2008

Analysis of clinical records of dental patients attending Jordan University Hospital: Documentation of drug prescriptions and local anesthetic injections

Najla Dar-Odeh, Soukaina Ryalat, Mohammad Shayyab, Osama Abu-Hammad

Therapeutics and Clinical Risk Management 2008, 4:1111-1117

Published Date: 10 October 2008

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis

V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al

Therapeutics and Clinical Risk Management 2008, 4:1105-1110

Published Date: 10 October 2008

Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials

Kyoko Taku, Keizo Umegaki, Yoshiko Ishimi, Shaw Watanabe

Therapeutics and Clinical Risk Management 2008, 4:1097-1103

Published Date: 10 October 2008

Bowen’s disease – a review of newer treatment options

Thorsten Neubert, Percy Lehmann

Therapeutics and Clinical Risk Management 2008, 4:1085-1095

Published Date: 10 October 2008

Weekly docetaxel in the treatment of metastatic breast cancer

Laura Palmeri, Marina Vaglica, Sergio Palmeri

Therapeutics and Clinical Risk Management 2008, 4:1047-1059

Published Date: 10 October 2008

Lopinavir/ritonavir in the treatment of HIV-1 infection: a review

Ashish Chandwani, Jonathan Shuter

Therapeutics and Clinical Risk Management 2008, 4:1023-1033

Published Date: 10 October 2008

Review of docetaxel in the treatment of gastric cancer

Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani

Therapeutics and Clinical Risk Management 2008, 4:999-1007

Published Date: 10 October 2008

Risk management profile of etoricoxib: an example of personalized medicine

Paola Patrignani, Stefania Tacconelli, Marta L Capone

Therapeutics and Clinical Risk Management 2008, 4:983-997

Published Date: 10 October 2008

Treatment of hereditary angioedema with plasma-derived C1 inhibitor

Michael J Prematta, Tracy Prematta, Timothy J Craig

Therapeutics and Clinical Risk Management 2008, 4:975-982

Published Date: 10 October 2008

Management of postoperative ileus: focus on alvimopan

Eric L Marderstein, Conor P Delaney

Therapeutics and Clinical Risk Management 2008, 4:965-973

Published Date: 10 October 2008

New advances in the treatment of Clostridium difficile infection (CDI)

Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K Farver

Therapeutics and Clinical Risk Management 2008, 4:949-964

Published Date: 10 October 2008

Multi-targeted approach in the treatment of thyroid cancer

Scott N Pinchot, Rebecca S Sippel, Herbert Chen

Therapeutics and Clinical Risk Management 2008, 4:935-947

Published Date: 10 October 2008

Treatment of Crohn’s disease with colony-stimulating factors: An overview

Luisa Guidi, Giammarco Mocci, Manuela Marzo, Sergio Rutella

Therapeutics and Clinical Risk Management 2008, 4:927-934

Published Date: 10 October 2008

Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Tarsila CR Ribeiro, Julio MF Chebli, Mario Kondo, Pedro Duarte Gaburri, Liliana Andrade Chebli, Ana Cristina Amaral Feldner

Therapeutics and Clinical Risk Management 2008, 4:919-925

Published Date: 10 October 2008

Postoperative ileus: strategies for reduction

James Lubawski, Theodore Saclarides

Therapeutics and Clinical Risk Management 2008, 4:913-917

Published Date: 10 October 2008

Evaluation of extended and continuous use oral contraceptives

Kristen Page Wright, Julia V Johnson

Therapeutics and Clinical Risk Management 2008, 4:905-911

Published Date: 10 October 2008

Pharmacological management of acute bronchiolitis

Melvin Wright, Charles J Mullett, Giovanni Piedimonte

Therapeutics and Clinical Risk Management 2008, 4:895-903

Published Date: 10 October 2008

Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate

Ismail A Mohammed, Alastair J Hutchison

Therapeutics and Clinical Risk Management 2008, 4:887-893

Published Date: 10 October 2008

Docetaxel in the treatment of squamous cell carcinoma of the head and neck

Alexander Rapidis, Nicholas Sarlis, Jean-Louis Lefebvre, Merrill Kies

Therapeutics and Clinical Risk Management 2008, 4:865-886

Published Date: 10 October 2008

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations

Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, Alberto Papi, Leonardo M Fabbri

Therapeutics and Clinical Risk Management 2008, 4:855-864

Published Date: 10 October 2008

Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis

Jessina C McGregor, George P Allen, David T Bearden

Therapeutics and Clinical Risk Management 2008, 4:843-853

Published Date: 10 October 2008